EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Identification of Inhibitors of the Disease-Associated Protein Phosphatase Scp1 Using Antibody Mimetic Molecules

Tamaki Kobayashi, Kazuki Yamazaki, Junki Shinada, Masataka Mizunuma, Kazuhiro Furukawa, Yoshiro Chuman iD

International Journal of Molecular Sciences · 2024

DOI: 10.3390/ijms25073737 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2024. Verfasst von Tamaki Kobayashi und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemistry, Faculty of Science, Niigata University, Niigata 950-2181, Japan. Hauptthemen laut MEDLINE: Antibodies, Fibronectin Type III Domain, Recombinant Proteins. Die Arbeit nennt 64 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Japan Society for the Promotion of Science, Japanese Society for the Promotion of Sciences.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Protein phosphorylation is a prevalent translational modification, and its dysregulation has been implicated in various diseases, including cancer. Despite its significance, there is a lack of specific inhibitors of the FCP/SCP-type Ser/Thr protein phosphatase Scp1, characterized by high specificity and affinity. In this study, we focused on adnectin, an antibody-mimetic protein, aiming to identify Scp1-specific binding molecules with a broad binding surface that target the substrate-recognition site of Scp1. Biopanning of Scp1 was performed using an adnectin-presenting phage library with a randomized FG loop. We succeeded in identifying FG-1Adn, which showed high affinity and specificity for Scp1. Ala scanning analysis of the Scp1-binding sequence in relation to the FG-1 peptide revealed that hydrophobic residues, including aromatic amino acids, play important roles in Scp1 recognition. Furthermore, FG-1Adn was found to co-localize with Scp1 in cells, especially on the plasma membrane. In addition, Western blotting analysis showed that FG-1Adn increased the phosphorylation level of the target protein of Scp1 in cells, indicating that FG-1Adn can inhibit the function of Scp1. These results suggest that FG-1Adn can be used as a specific inhibitor of Scp1.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AntibodiesFibronectin Type III DomainRecombinant ProteinsAmino Acids, AromaticPhosphoprotein PhosphatasesPeptide Library

Stichwörter der Autor:innen

Scp1adnectinanticancer drugphage display libraryprotein phosphatase

Substanzen

Amino Acids, AromaticAntibodiesPhosphoprotein PhosphatasesRecombinant ProteinsPeptide Libraryadnectin

Autor:innen und Institutionen

  • Department of Chemistry, Faculty of Science, Niigata University, Niigata 950-2181, Japan.

ORCID-Profile: Yoshiro Chuman

Förderung

  • Japan Society for the Promotion of Science
  • Japanese Society for the Promotion of Sciences

Zitieren

APA

Kobayashi, T., Yamazaki, K., Shinada, J., Mizunuma, M., Furukawa, K., & Chuman, Y. (2024). Identification of Inhibitors of the Disease-Associated Protein Phosphatase Scp1 Using Antibody Mimetic Molecules. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms25073737

Vancouver

Kobayashi T, Yamazaki K, Shinada J, Mizunuma M, Furukawa K, Chuman Y. Identification of Inhibitors of the Disease-Associated Protein Phosphatase Scp1 Using Antibody Mimetic Molecules. International Journal of Molecular Sciences. 2024. doi:10.3390/ijms25073737

BibTeX
@article{Kobayashi2024,
  author = {Kobayashi, Tamaki and Yamazaki, Kazuki and Shinada, Junki and Mizunuma, Masataka and Furukawa, Kazuhiro and Chuman, Yoshiro},
  title = {Identification of Inhibitors of the Disease-Associated Protein Phosphatase Scp1 Using Antibody Mimetic Molecules},
  journal = {International Journal of Molecular Sciences},
  year = {2024},
  doi = {10.3390/ijms25073737}
}
Kostenlos starten →